These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 30419607)

  • 1. Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer.
    Ozkurt E; Yardımcı E; Tükenmez M; Ersoy YE; Yilmaz R; Cabioğlu N; Karanlık H; Kulle CB; Malya FU; Önder S; Gucin Z; İğci A; Özmen V; Dinççağ AS; Müslümanoğlu M
    Breast J; 2019 Jan; 25(1):96-102. PubMed ID: 30419607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.
    Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT
    Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intraoperative assessment of sentinel nodes - Standards and controversies.
    van der Noordaa MEM; Vrancken Peeters MTFD; Rutgers EJT
    Breast; 2017 Aug; 34 Suppl 1():S64-S69. PubMed ID: 28673534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
    Imoto S; Yamauchi C; Komoike Y; Tsugawa K; Yotsumoto D; Wada N; Ueno T; Oba MS; Shien T; Sugae S; Tsuda H; Yoneyama K
    Breast Cancer; 2017 May; 24(3):427-432. PubMed ID: 27553957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of sentinel lymph node biopsy prior to axillary lymph node dissection: the role of isolated tumor cells/micrometastases and multifocality/multicentricity-a retrospective study of 1214 breast cancer patients.
    Schröder L; Fricker R; Stein RG; Rink T; Fitz H; Blasius S; Wöckel A; Müller T
    Arch Gynecol Obstet; 2018 Jun; 297(6):1509-1515. PubMed ID: 29594495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary treatment of patients with breast cancer and micrometastatic disease in the sentinel lymph node Our experience.
    Morlino A; La Torre G; Patitucci G; Cammarota A
    Ann Ital Chir; 2017; 88():360-364. PubMed ID: 29051403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront Mastectomy.
    Pride RM; Glass CC; Nakhlis F; Laws A; Weiss AC; Bellon JR; Mittendorf EA; King TA; Kantor O
    Ann Surg Oncol; 2023 Oct; 30(10):5978-5987. PubMed ID: 37436607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.
    Tadros AB; Moo TA; Stempel M; Zabor EC; Khan AJ; Morrow M
    Breast Cancer Res Treat; 2020 Feb; 180(1):197-205. PubMed ID: 31938938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of non-sentinel lymph node metastasis in breast cancer with 1-2 sentinel lymph node macrometastases underwent total mastectomy: a case-control study.
    Huang Z; Wu Z; Zou QQ; Xie YJ; Li LH; Huang YP; Wu FM; Huang D; Pan YH; Yang JR
    World J Surg Oncol; 2023 Apr; 21(1):125. PubMed ID: 37024930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.
    Costaz H; Boulle D; Bertaut A; Rouffiac M; Beltjens F; Desmoulins I; Peignaux K; Ladoire S; Causeret S; Loustalot C; Padeano MM; Vincent L; Jankowski C; Arnould L; Coutant C
    Bull Cancer; 2022 Mar; 109(3):268-279. PubMed ID: 34838310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study.
    Hennigs A; Riedel F; Feißt M; Köpke M; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Heil J
    Ann Surg Oncol; 2019 Aug; 26(8):2435-2443. PubMed ID: 31049766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of frozen section in sentinel lymph node biopsy for breast cancer in the era of the ACOSOG Z0011 and IBCSG 23-10 trials.
    Lombardi A; Nigri G; Maggi S; Stanzani G; Vitale V; Vecchione A; Nania A; Amanti C
    Surgeon; 2018 Aug; 16(4):232-236. PubMed ID: 29329752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
    Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
    J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
    Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
    Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
    Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
    Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer.
    Carmon M; Olsha O; Rivkin L; Spira RM; Golomb E
    Breast J; 2006; 12(3):199-201. PubMed ID: 16684315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy.
    Chun JW; Kang E; Kim HK; Lee HB; Moon HG; Lee JW; Han W
    Ann Surg Oncol; 2024 May; 31(5):3168-3176. PubMed ID: 38368292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimization of sentinel lymph node biopsy in breast cancer by intraoperative axillary palpation].
    Serrano Vicente J; Infante de la Torre JR; Domínguez Grande ML; García Bernardo L; Durán Barquero C; Rayo Madrid JI; Sánchez Sánchez R; Correa Antúnez MI; Amaya Lozano JL; Conde Martín AF
    Rev Esp Med Nucl; 2010; 29(1):8-11. PubMed ID: 20015577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer.
    Akay CL; Albarracin C; Torstenson T; Bassett R; Mittendorf EA; Yi M; Kuerer HM; Babiera GV; Bedrosian I; Hunt KK; Hwang RF
    Breast J; 2018 Jan; 24(1):28-34. PubMed ID: 28608612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.